| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |